Order Article Reprints

Stewart DJ, Bradford J-P, Sehdev S, Ramsay T, Navani V, Rawson NSB, Jiang DM, Gotfrit J, Wheatley-Price P, Liu G, et al. New Anticancer Drugs: Reliably Assessing “Value” While Addressing High Prices. Current Oncology. 2024; 31(5):2453-2480. https://doi.org/10.3390/curroncol31050184

Stewart, David J., John-Peter Bradford, Sandeep Sehdev, Tim Ramsay, Vishal Navani, Nigel S. B. Rawson, Di Maria Jiang, Joanna Gotfrit, Paul Wheatley-Price, Geoffrey Liu, and et al. 2024. "New Anticancer Drugs: Reliably Assessing “Value” While Addressing High Prices" Current Oncology 31, no. 5: 2453-2480. https://doi.org/10.3390/curroncol31050184

Stewart, D. J., Bradford, J.-P., Sehdev, S., Ramsay, T., Navani, V., Rawson, N. S. B., Jiang, D. M., Gotfrit, J., Wheatley-Price, P., Liu, G., Kaplan, A., Spadafora, S., Goodman, S. G., Auer, R. A. C., & Batist, G. (2024). New Anticancer Drugs: Reliably Assessing “Value” While Addressing High Prices. Current Oncology, 31(5), 2453-2480. https://doi.org/10.3390/curroncol31050184